The frequency of exclusive membrane staining of HER-3 were also reported in studies on primary tumors in CRC patients by Ledel et al. [29] (n = 236) and in colon cancer patients by Beji et al. [34] (n = 110). This evidence concerns the gene ERBB3 and malignant colon neoplasm.